Transplantation Proceedings
Volume 33, Issue 7 , Pages 3092-3093, November 2001

Benefits of cyclosporine microemulsion (Neoral) C2 monitoring are sustained at 1 year in de novo liver transplant recipients☆

  • J.R. Lake

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Dr John R. Lake, Department of Medicine, University of Minnesota, 420 Delaware Street SE, Box 36, Minneapolis, MN 55455 USA
    • Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
    • ,
  • Neo-INT-06 Study Group

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by Novartis Pharma AG, Basel, Switzerland.

PII: S0041-1345(01)02317-X

Transplantation Proceedings
Volume 33, Issue 7 , Pages 3092-3093, November 2001

Article Tools